Bionano Genomics To Acquire Purigen Biosystems To Enable Further Simplified And Accelerated Dna Isolation For Optical Genome Mapping (Ogm) And Address Difficult Sample Types In New Applications With Isotachophoresis (Itp) On The Ionic Purification System
Acquiring Company
Bionano Genomics, Inc.
Acquired Company
Purigen Biosystems
San DiegoBioinformaticsGeneticsBiotechnologyHealth CareSoftwareBiotechnologyDescription
Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that it has entered into a definitive agreement to acquire Purigen Biosystems, Inc. (Purigen), a company that develops and commercializes automated nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology, which was licensed exclusively from Stanford and developed by Purigen. Purigen’s ITP technology is a solution-based purification approach and therefore different from protocols in routine use today, which tend to rely on binding to a matrix, washing and then removal from the matrix. Those protocols are less efficient at capturing molecules from dilute solutions or from samples with small amounts of cells and often result in shorter average lengths of DNA than what optical genome mapping (OGM) requires. The transaction is expected to accelerate the adoption of OGM due to anticipated improvements in its ultra high molecular weight (UHMW) DNA sample preparation workflow.